Fig. 5From: Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trialPlot with the mean change from baseline in the SCORE and PCE 10-year estimated CV risk after 16 weeks or treatment with the CNIC-polypill strategy and usual care. SD standard deviation, PCE US-derived Pooled Cohort Risk Equations; SCORE European Systematic Coronary Risk EvaluationBack to article page